4NX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lumos Pharma Inc

Watchlist Manager

Watchlist

Price: 6.25 EUR -3.1% Market Closed

Market Cap: €52.5m

L	Lumos Pharma Inc F:4NX1	US
K	Klondike Gold Corp OTC:KDKGF	CA
	Medley Inc F:3YV	JP
	Radial Research Corp OTC:RADLD	CA
	Bellevue Group AG LSE:0QLZ	CH
	Digital Hearts Holdings Co Ltd F:957	JP
S	SThree PLC XBER:S8T	UK
L	Liechtensteinische Landesbank AG F:LLS1	LI
N	NEXE Innovations Inc OTC:NEXNF	CA
	OncoTherapy Science Inc F:30O	JP
T	Tombill Mines Ltd OTC:TBLLF	CA
E	Eniblock SA F:K26	FR
N	New Age Metals Inc F:P7J2	CA
	Granite Creek Copper Ltd F:GRK	CA
	Orbis Se LSE:0FGS	DE
	Medley Inc OTC:MDLYF	JP
U	United Security Bancshares F:4QR	US

Profitability Summary

Lumos Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 648%

Negative 3Y Average Operating Margin

-2 138%

Declining Operating Margin

-1 545% > -1 648%

Negative Net Margin

-1 583%

Negative 3Y Average Net Margin

-2 014%

Declining Net Margin

-1 441% > -1 583%

Negative Free Cash Flow Margin

-1 437%

Negative 3Y Average Free Cash Flow Margin

-1 870%

Declining Free Cash Flow Margin

-1 236% > -1 437%

Negative ROE

-173%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-861%

Declining ROIC

-660% > -1 025%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.